Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03570112 · ClinicalTrials.gov registry record
Transmission of Chronic Hepatitis C in Pregnancy
A clinical trial, sponsored by The Christ Hospital.
- Completed
- Registry status
- 40
- Enrollment target
NCT03570112 is a clinical trial that has completed, run by The Christ Hospital. The registered enrollment target is 40 participants.
The verdict
NCT03570112 has completed, sponsored by The Christ Hospital.
- COMPLETED
- Registry status
- 40 participants
- Enrollment target
Study Summary
This is a multicenter, non-comparative, observational study that will recruit women with singleton pregnancy and chronic HCV infection to determine the natural history of chronic HCV in pregnancy and the rate of vertical transmission to their infants. All participants will be offered curative therapy with sofosbuvir/velpatasvir (Epclusa ®) after delivery and the cessation of breastfeeding. Subjects may be enrolled at any time after conception up through 36 weeks gestation. The management of subjects in pregnancy will be in accordance with ACOG guidelines and individual clinical judgment, however testing will include, but not be limited to, testing for HCV infection, HIV infection, HBV infection, HSV infection, group B Streptococcal colonization, HCV genotype, HCV viral load, as well as assessment of hepatic and renal function. Subjects will be followed on a schedule that is determined by their obstetric care providers throughout their pregnancy. Following delivery, infants will be evaluated at 12, 24 and 48 weeks of age, with testing for HCV RNA to be obtained at each evaluation. Vertical transmission is defined as two positive HCV RNA PCR tests, at least one before the 48 week infant visit, and again at the 12-month follow-up infant visit.
Interventions
- DRUG SOF/VEL- sofosbuvir 400mg and velpatasvir 100mg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2018-06-08 |
| Est. Completion | 2023-02-27 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03570112
The ClinicalTrials.gov registry entry for NCT03570112 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Christ Hospital, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which SOF/VEL- sofosbuvir 400mg and velpatasvir 100mg is the first listed.
NCT03570112 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03570112 about?
NCT03570112 is a clinical study titled "Transmission of Chronic Hepatitis C in Pregnancy". This is a multicenter, non-comparative, observational study that will recruit women with singleton pregnancy and chronic HCV infection to determine the natural history of chronic HCV in pregnancy and the rate of vertical transmission to their infants. All participants will be offered curative therap...
What is the current status of trial NCT03570112?
This trial is currently completed. The enrollment target is 40 participants. The study started on 2018-06-08. Estimated completion is 2023-02-27.
What interventions are being tested in trial NCT03570112?
The interventions under investigation include: SOF/VEL- sofosbuvir 400mg and velpatasvir 100mg (DRUG).
Who is sponsoring clinical trial NCT03570112?
This trial is sponsored by The Christ Hospital, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.